Steven Avruch
General Counsel at AVROBIO, INC.
Net worth: 26 096 $ as of 30/04/2024
Network origin in Steven Avruch first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
103
| Public Company | Pharmaceuticals: Major | 103 |
| Public Company | Biotechnology | 29 | |
Boston Center for the Arts
5
| Non-Profit Organization | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Steven Avruch via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Founder | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President President | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder President Corporate Officer/Principal Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer Comptroller/Controller/Auditor | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| Boston University | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Executive Officer General Counsel Corporate Officer/Principal | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOVERATIV INC | Biotechnology | Chief Executive Officer General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member General Counsel Compliance Officer | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Chief Executive Officer Chief Operating Officer |
Statistics
International
| United States | 42 |
| Israel | 3 |
| Canada | 3 |
| Ireland | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 15 |
| Finance | 5 |
| Consumer Non-Durables | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 350 |
| Corporate Officer/Principal | 197 |
| Independent Dir/Board Member | 98 |
| Undergraduate Degree | 77 |
| Chief Executive Officer | 66 |
Most connected contacts
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Bruce Booth | 40 |
| Ian Clark | 35 |
| George Scangos | 33 |
| William Young | 32 |
| Steven Holtzman | 28 |
| Douglas Williams | 25 |
| Joanne Viney | 18 |
| Glenn F. Pierce | 17 |
| Adriana Karaboutis | 16 |
| John Cox | 15 |
| Gail Farfel | 15 |
| Spyridon Artavanis-Tsakonas | 15 |
| Philip Donenberg | 15 |
| Geoff MacKay | 15 |
- Stock Market
- Insiders
- Steven Avruch
- Company connections
